VTV Therapeutics Inc. Class AVTVT
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 45 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, up 10 from Q1 2026. 17 opened new positions and 6 sold out. The largest holders were Samsara Biocapital, LLC ($11.2M), Millennium Management ($10.2M) and FMR LLC ($9.8M). 4 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $5.7M |
| Exits | 6 | $1.7M |
All 13F filers, Q1 2026 → Q2 2026: 247,357 shares bought and 127,473 shares sold, net +119,884 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Samsara Biocapital, LLC | 0.92% | No change | 298,496 | $11.2M |
| Millennium Management | 0.01% | Add +30.8% | 269,874 | $10.2M |
| FMR LLC | 0.00% | No change | 260,391 | $9.8M |
| Siren, L.L.C. | 0.12% | No change | 163,000 | $6.1M |
| Baker Bros. Advisors LP | 0.03% | No change | 148,314 | $5.6M |
| Vanguard Capital Management LLC | 0.00% | Reduce -13.3% | 94,463 | $3.6M |
| Trails Edge Capital Partners, LP | 0.51% | Reduce -39.0% | 85,192 | $3.2M |
| Aisling Capital Management LP | 0.40% | New | 50,000 | $1.9M |
| Marshall Wace, LLP | 0.00% | Add +195.5% | 39,560 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Reduce -1.3% | 32,470 | $1.2M |
| Renaissance Technologies | 0.00% | New | 17,454 | $657K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 16,239 | $611K |
| BlackRock, Inc. | 0.00% | Add +16.9% | 14,731 | $555K |
| Jane Street Group, LLC | 0.00% | New | 13,703 | $516K |
| State Street Corp. | 0.00% | Add +15.0% | 12,266 | $462K |
| Two Sigma Investments, LP | 0.00% | New | 11,486 | $432K |
| Verdad Advisers, LP | 0.32% | New | 8,996 | $339K |
| Integrated Quantitative Investments LLC | 0.05% | New | 8,210 | $309K |
| Susquehanna International Group, LLP | 0.00% | New | 8,023 | $302K |
| Quadrature Capital Ltd | 0.00% | New | 6,305 | $237K |
| Trexquant Investment LP | 0.00% | New | 6,240 | $235K |
| Northern Trust Corp. | 0.00% | Reduce -66.1% | 6,123 | $231K |
| Pathstone Holdings, LLC | 0.00% | No change | 6,073 | $229K |
| Point72 Asset Management | 0.00% | New | 5,947 | $224K |
| HRT Financial LP | 0.00% | New | 5,923 | $223K |
| Citadel Advisors | 0.00% | New | 5,906 | $222K |
| China Universal Asset Management Co., Ltd. | 0.01% | New | 2,500 | $94K |
| UBS Group AG | 0.00% | Reduce -61.4% | 2,175 | $82K |
| BNP Paribas Financial Markets | 0.00% | Add +19922.2% | 1,802 | $68K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 1,275 | $48K |
| Osaic Holdings, Inc. | 0.00% | Reduce -8.8% | 1,020 | $38K |
| Morgan Stanley | 0.00% | Reduce -12.6% | 1,009 | $38K |
| Valley National Advisers Inc. | 0.00% | New | 980 | $37K |
| Farther Finance Advisors, LLC | 0.00% | No change | 283 | $11K |
| Strengthening Families & Communities, LLC | 0.00% | No change | 173 | $7K |
| State of Wyoming | 0.00% | New | 147 | $6K |
| Truvestments Capital LLC | 0.00% | New | 143 | $5K |
| Bessemer Group Inc. | 0.00% | No change | 112 | $4K |
| Activest Wealth Management | 0.00% | No change | 50 | $2K |
| CoreCap Advisors, LLC | 0.00% | No change | 45 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $75 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $75 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 1 | $38 |
| Royal Bank of Canada | 0.00% | Reduce -93.0% | 3 | $0 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.